社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
基石药业-B(02616)
5.010
+0.080
+1.62%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
基石药业-B
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.cstonepharma.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
基石药业是一家主要从事肿瘤、自身免疫和炎症及其他关键疾病领域药物研发及销售的投资控股公司。该公司通过子公司主要从事生物制药产品的研发、药品的销售及提供其知识产权（IP）授权或商业化授权。该公司产品主要包括精准治疗药物“泰吉华”（阿伐替尼）及“普吉华”（普拉替尼）、以及“择捷美”（舒格利单抗）等。该公司还从事肿瘤免疫药物的开发及商业化。该公司主要在中国国内市场、以及中欧、东欧和瑞士等海外市场开展业务。
06-01 21:09
股份购回
建议发行及购回股份的一般授权、重选退任董事、续聘核数师、建议根据首次公开发售后雇员持股计划及首次公开发售后受限制股份奖励计划向董事兼首席执行官授出购股权及受限制股份单位及股东周年大会通告
建议发行及购回股份的一般授权、重选退任董事、续聘核数师、建议根据首次公开发售后雇员持股计划及首次公开发售后受限制股份奖励计划向董事兼首席执行官授出购股权及受限制股份单位及股东周年大会通告
04-27
年度报告
2025年年报
2025年年报
04-22
股份发行
完成根据一般授权配售新股
完成根据一般授权配售新股
04-15
股份发行
根据一般授权配售新股
根据一般授权配售新股
03-26
年度报告
截至二零二五年十二月三十一日止年度之年度业绩公告
截至二零二五年十二月三十一日止年度之年度业绩公告
2025-09-29
半年度报告
2025年中期报告
2025年中期报告
2025-08-14
半年度报告
截至二零二五年六月三十日止六个月中期业绩公告
截至二零二五年六月三十日止六个月中期业绩公告
2025-07-16
股份发行
完成根据一般授权配售新股
完成根据一般授权配售新股
2025-07-09
股份发行
根据一般授权配售新股
根据一般授权配售新股
2025-06-03
股份购回
建议发行及购回股份的一般授权、重选退任董事、续聘核数师及股东周年大会通告
建议发行及购回股份的一般授权、重选退任董事、续聘核数师及股东周年大会通告
2025-04-28
年度报告
2024年年报
2024年年报
2025-04-10
股份发行
完成根据一般授权配售新股
完成根据一般授权配售新股
2025-04-02
股份发行
根据一般授权配售新股
根据一般授权配售新股
2025-03-27
年度报告
截至二零二四年十二月三十一日止年度之年度业绩公告
截至二零二四年十二月三十一日止年度之年度业绩公告
2024-09-26
半年度报告
2024年中期报告
2024年中期报告
分时
5日
日
周
月
数据加载中...
最高
5.150
今开
5.000
量比
0.38
最低
4.890
昨收
4.930
换手率
0.69%
热议股票
{"pagemeta":{"title":"基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基石药业-B(02616)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基石药业-B,02616,基石药业-B股票,基石药业-B股票老虎,基石药业-B股票老虎国际,基石药业-B行情,基石药业-B股票行情,基石药业-B股价,基石药业-B股市,基石药业-B股票价格,基石药业-B股票交易,基石药业-B股票购买,基石药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基石药业-B(02616)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"02616","data":{"stockData":{"symbol":"02616","market":"HK","secType":"STK","nameCN":"基石药业-B","latestPrice":5.01,"timestamp":1780560493007,"preClose":4.93,"halted":0,"volume":11106165,"delay":0,"changeRate":0.01622718052738338,"floatShares":1600000000,"shares":1600000000,"eps":-0.314752,"marketStatus":"已收盘","change":0.08,"latestTime":"06-04 16:08:13","open":5,"high":5.15,"low":4.89,"amount":55638049,"amplitude":0.052738,"askPrice":5.02,"askSize":5000,"bidPrice":5.01,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-0.302,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780623000000},"marketStatusCode":5,"adr":0,"listingDate":1551110400000,"exchange":"SEHK","adjPreClose":4.93,"openAndCloseTimeList":[[1780536600000,1780545600000],[1780549200000,1780560000000]],"volumeRatio":0.383508,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"21336854","market":"hk","labels":[],"media":"港交所","original_id":"N.HKEYp65cW2j9","pdf_url":"https://static.tigerbbs.com/e15e01bb76fc4aaa865a49f555e31193","pub_time":1780319340000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议发行及购回股份的一般授权、重选退任董事、续聘核数师、建议根据首次公开发售后雇员持股计划及首次公开发售后受限制股份奖励计划向董事兼首席执行官授出购股权及受限制股份单位及股东周年大会通告","symbol":"02616","title":"建议发行及购回股份的一般授权、重选退任董事、续聘核数师、建议根据首次公开发售后雇员持股计划及首次公开发售后受限制股份奖励计划向董事兼首席执行官授出购股权及受限制股份单位及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0601/2026060103775_c.pdf","us_notice_code":"通函 - [一般性授权 / 在股东批准的情况下重选或委任董事 / 回购股份的说明函件 / 股份计划]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2026-06-01 21:09","pubTimestamp":1780319340,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"21115831","market":"hk","labels":[],"media":"港交所","original_id":"N.HKBu8NrBxYUD","pdf_url":"https://static.tigerbbs.com/b29e508fb3ea4c69b14ab2920e7268cc","pub_time":1777283880000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025年年报","symbol":"02616","title":"2025年年报","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042701896_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2026-04-27 17:58","pubTimestamp":1777283880,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"21064628","market":"hk","labels":[],"media":"港交所","original_id":"N.HK9vKGp3vJGD","pdf_url":"https://static.tigerbbs.com/1dea7f72a6f348a8a5e63b0b97efe2bd","pub_time":1776865440000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售新股","symbol":"02616","title":"完成根据一般授权配售新股","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0422/2026042201923_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2026-04-22 21:44","pubTimestamp":1776865440,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"21001957","market":"hk","labels":[],"media":"港交所","original_id":"N.HK4KYztN2mAQ","pdf_url":"https://static.tigerbbs.com/fc89d70be41c41219eb449330a250c52","pub_time":1776208020000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股","symbol":"02616","title":"根据一般授权配售新股","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0415/2026041500092_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2026-04-15 07:07","pubTimestamp":1776208020,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20892087","market":"hk","labels":[],"media":"港交所","original_id":"N.HKFaTiWhJxHv","pdf_url":"https://static.tigerbbs.com/e75a28aa6229461f9e85f43970844bf2","pub_time":1774528920000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至二零二五年十二月三十一日止年度之年度业绩公告","symbol":"02616","title":"截至二零二五年十二月三十一日止年度之年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0326/2026032601811_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2026-03-26 20:42","pubTimestamp":1774528920,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20220429","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGgcNdmqGwq","pdf_url":"https://static.tigerbbs.com/8ca8c3b4a65541219b3c41e95b5a887d","pub_time":1759147860000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025年中期报告","symbol":"02616","title":"2025年中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0929/2025092902411_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-29 20:11","pubTimestamp":1759147860,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19986305","market":"hk","labels":[],"media":"港交所","original_id":"N.HKANbk7HnGb7","pdf_url":"https://static.tigerbbs.com/846a40866ddd47afbaadaddc7cc04b21","pub_time":1755169320000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至二零二五年六月三十日止六个月中期业绩公告","symbol":"02616","title":"截至二零二五年六月三十日止六个月中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0814/2025081401221_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-08-14 19:02","pubTimestamp":1755169320,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19884301","market":"hk","labels":[],"media":"港交所","original_id":"N.HK5QvRNxFsKj","pdf_url":"https://static.tigerbbs.com/c4221b37fb1a450aa673ad08d1dc45df","pub_time":1752676680000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售新股","symbol":"02616","title":"完成根据一般授权配售新股","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0716/2025071601180_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-07-16 22:38","pubTimestamp":1752676680,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19860109","market":"hk","labels":[],"media":"港交所","original_id":"N.HK5H7Hjk8uah","pdf_url":"https://static.tigerbbs.com/5acf8dc024514471b866cf3c18cfb63f","pub_time":1752019200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股","symbol":"02616","title":"根据一般授权配售新股","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0709/2025070900032_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-07-09 08:00","pubTimestamp":1752019200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19726094","market":"hk","labels":[],"media":"港交所","original_id":"N.HKDa3STZm7do","pdf_url":"https://static.tigerbbs.com/f381d7a17e3d4d648bd2e996a52e0964","pub_time":1748950200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议发行及购回股份的一般授权、重选退任董事、续聘核数师及股东周年大会通告","symbol":"02616","title":"建议发行及购回股份的一般授权、重选退任董事、续聘核数师及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0603/2025060302376_c.pdf","us_notice_code":"通函 - [一般性授权 / 在股东批准的情况下重选或委任董事 / 回购股份的说明函件]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2025-06-03 19:30","pubTimestamp":1748950200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19539717","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGk7wUMEFrb","pdf_url":"https://static.tigerbbs.com/cc68a739859d4b3cb85240e8fbb4e9a8","pub_time":1745841900000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024年年报","symbol":"02616","title":"2024年年报","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0428/2025042803586_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-04-28 20:05","pubTimestamp":1745841900,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19373260","market":"hk","labels":[],"media":"港交所","original_id":"N.HKFkEpxHqYU1","pdf_url":"https://static.tigerbbs.com/f886dd707c3f434f8640d1d12cb57709","pub_time":1744284180000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售新股","symbol":"02616","title":"完成根据一般授权配售新股","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0410/2025041001176_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-04-10 19:23","pubTimestamp":1744284180,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19335426","market":"hk","labels":[],"media":"港交所","original_id":"N.HK5i6eVa45ci","pdf_url":"https://static.tigerbbs.com/41cf9535429049cfb5eff52a30495287","pub_time":1743552000000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股","symbol":"02616","title":"根据一般授权配售新股","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0402/2025040200052_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-04-02 08:00","pubTimestamp":1743552000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19291173","market":"hk","labels":[],"media":"港交所","original_id":"N.HKBMuuGBJaUe","pdf_url":"https://static.tigerbbs.com/6533786fae3f46f5b3f38546ef3b5f9a","pub_time":1743064200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至二零二四年十二月三十一日止年度之年度业绩公告","symbol":"02616","title":"截至二零二四年十二月三十一日止年度之年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0327/2025032700404_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-03-27 16:30","pubTimestamp":1743064200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18648990","market":"hk","labels":[],"media":"港交所","original_id":"N.HK9cWqdUGdk3","pdf_url":"https://static.tigerbbs.com/1ffd22ac87c1492f8479f32b2bc9232c","pub_time":1727341200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024年中期报告","symbol":"02616","title":"2024年中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0926/2024092601070_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-09-26 17:00","pubTimestamp":1727341200,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.cstonepharma.com","stockEarnings":[{"period":"1week","weight":-0.3688},{"period":"1month","weight":-0.4727},{"period":"3month","weight":-0.2333},{"period":"6month","weight":-0.1305},{"period":"1year","weight":0.2143},{"period":"ytd","weight":-0.0645}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":-0.0177},{"period":"3month","weight":0.0123},{"period":"6month","weight":-0.0173},{"period":"1year","weight":0.0902},{"period":"ytd","weight":0.0001}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"基石药业是一家主要从事肿瘤、自身免疫和炎症及其他关键疾病领域药物研发及销售的投资控股公司。该公司通过子公司主要从事生物制药产品的研发、药品的销售及提供其知识产权（IP）授权或商业化授权。该公司产品主要包括精准治疗药物“泰吉华”（阿伐替尼）及“普吉华”（普拉替尼）、以及“择捷美”（舒格利单抗）等。该公司还从事肿瘤免疫药物的开发及商业化。该公司主要在中国国内市场、以及中欧、东欧和瑞士等海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.050688},{"month":2,"riseRate":0.428571,"avgChangeRate":0.069097},{"month":3,"riseRate":0.25,"avgChangeRate":-0.053883},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.031371},{"month":5,"riseRate":0.428571,"avgChangeRate":0.066954},{"month":6,"riseRate":0.625,"avgChangeRate":0.034179},{"month":7,"riseRate":0.571429,"avgChangeRate":0.05639},{"month":8,"riseRate":0.428571,"avgChangeRate":0.079119},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.071005},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.012196},{"month":11,"riseRate":0.571429,"avgChangeRate":0.010396},{"month":12,"riseRate":0.428571,"avgChangeRate":0.004524}],"exchange":"SEHK","name":"基石药业-B","nameEN":"CSTONE PHARMA-B"},"aProfile":null}}}